glutamic acid has been researched along with dobutamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Guo, NN; Li, SH; Liu, Y; Luo, F; Tang, H; Zhang, Y | 1 |
Ishiguro, M; Kakizaki, R; Narimatsu, E; Nomura, K; Sawamoto, K; Takahashi, K; Uemura, S | 1 |
3 other study(ies) available for glutamic acid and dobutamine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Reduction of glutamate release probability and the number of releasable vesicles are required for suppression of glutamatergic transmission by β1-adrenoceptors in the medial prefrontal cortex.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Dobutamine; Glutamic Acid; Prefrontal Cortex; Pyramidal Cells; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Synaptic Transmission; Synaptic Vesicles | 2014 |
Dexmedetomidine improves excessive extracellular glutamate-induced synaptic depression (BRAINRES-D-21-00941).
Topics: Animals; Depression; Dexmedetomidine; Dobutamine; Glutamic Acid; Hippocampus; Isoproterenol; Rats; Receptors, Adrenergic; Synaptic Transmission | 2022 |